Holding(s) in Company
MATHENZ MARC KAY has notified Thalia Therapeutics PLC that their holding of voting rights has changed due to participation in a fundraising and subsequent dilution following an acquisition for shares that completed on 18 July 2026. As a result, their voting rights attached to shares now stand at 5.6315%, representing 100,000,000 voting rights, a decrease from their previous holding of 8.89%. This notification was made on 4 August 2026.
Select text to share a quote on X · sign in to keep highlights & notes in your THAT notes
| 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii : | Thalia Therapeutics |
- Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)
Non-UK issuer
- Reason for the notification (please mark the appropriate box or boxes with an "X")
An acquisition or disposal of voting rights
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
| Other (please specify) iii : Participation in fundraising and subsequent dilution following an acquisition for shares which completed on 18 July 2026 | X |
Details of person subject to the notification obligation iv
| Name | MATHENZ MARC KAY |
City and country of registered office (if applicable)
Full name of shareholder(s) (if different from 3.) v
Name
City and country of registered office (if applicable)
| 5. Date on which the threshold was crossed or reached vi : | 18 July 2026 |
| 6. Date on which issuer notified (DD/MM/YYYY): | 4 Aug 2026 |
- Total positions of person(s) subject to the notification obligation
| Resulting situation on the date on which threshold was crossed or reached | 5.6315% | 100,000,000 | |
| Position of previous notification (if applicable) | 8.89% | ||
| A: Voting rights attached to shares | |||
| Class/type of shares ISIN code (if possible) | Number of voting rights ix | % of voting rights | |
| Direct (DTR5.1) | Indirect (DTR5.2.1) | Direct (DTR5.1) | Indirect (DTR5.2.1) |
| GB00BYW8QM32 | 100,000,000 | 5.6315% | |
| SUBTOTAL 8. A | 100,000,000 | 5.6315% | |
B 1: Financial Instruments according to DTR5.3.1R (1) (a)
SUBTOTAL 8. B 1
B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)
SUBTOTAL 8.B.2
In case of proxy voting, please identify:
| Name of the proxy holder | UOB KAY HIAN PRIVATE LIMITED |
| The number and % of voting rights held | 100,000,000 (5.6315%) |
| The date until which the voting rights will be held | N/A |
| 11. Additional information xvi | |
| Place of completion | SINGAPORE |
| Date of completion | 4 AUGUST 2026 |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.